eXoZymes, Inc. (EXOZ)
6.25
-0.18
(-2.87%)
USD |
NASDAQ |
Sep 21, 16:00
6.25
0.00 (0.00%)
After-Hours: 20:00
eXoZymes Enterprise Value : 55.16M for Sept. 18, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 55.16M |
| September 17, 2026 | 52.88M |
| September 16, 2026 | 52.61M |
| September 15, 2026 | 56.46M |
| September 14, 2026 | 53.72M |
| September 11, 2026 | 53.92M |
| September 10, 2026 | 52.70M |
| September 09, 2026 | 52.70M |
| September 08, 2026 | 54.00M |
| September 04, 2026 | 59.01M |
| September 03, 2026 | 58.55M |
| September 02, 2026 | 58.45M |
| September 01, 2026 | 55.76M |
| August 31, 2026 | 57.90M |
| August 28, 2026 | 61.96M |
| August 27, 2026 | 62.03M |
| August 26, 2026 | 65.27M |
| August 25, 2026 | 65.32M |
| August 24, 2026 | 59.94M |
| August 21, 2026 | 61.79M |
| August 20, 2026 | 60.77M |
| August 19, 2026 | 54.83M |
| August 18, 2026 | 54.74M |
| August 17, 2026 | 51.40M |
| August 14, 2026 | 49.45M |
| Date | Value |
|---|---|
| August 13, 2026 | 51.12M |
| August 12, 2026 | 48.89M |
| August 11, 2026 | 48.89M |
| August 10, 2026 | 43.70M |
| August 07, 2026 | 42.81M |
| August 06, 2026 | 43.37M |
| August 05, 2026 | 45.92M |
| August 04, 2026 | 38.31M |
| August 03, 2026 | 38.13M |
| July 31, 2026 | 38.59M |
| July 30, 2026 | 38.13M |
| July 29, 2026 | 36.27M |
| July 28, 2026 | 36.27M |
| July 27, 2026 | 37.66M |
| July 24, 2026 | 39.15M |
| July 23, 2026 | 39.05M |
| July 22, 2026 | 43.05M |
| July 21, 2026 | 44.86M |
| July 20, 2026 | 47.41M |
| July 17, 2026 | 51.31M |
| July 16, 2026 | 53.16M |
| July 15, 2026 | 52.23M |
| July 14, 2026 | 60.40M |
| July 13, 2026 | 54.55M |
| July 10, 2026 | 60.12M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Anika Therapeutics, Inc. | 265.34M |
| Perspective Therapeutics, Inc. | 95.66M |
| MiMedx Group, Inc. | 576.47M |
| ABVC BioPharma, Inc. | 34.67M |
| bioAffinity Technologies, Inc. | 3.270M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.879M |
| Total Expenses (Quarterly) | 2.879M |
| EPS Diluted (Quarterly) | -0.3324 |
| Earnings Yield | -19.23% |
| Normalized Earnings Yield | -19.45 |